“…Among the many reasons for TLS deregulation are changes in the expression of the polymerase catalyzing lesion bypass; mutations in the TLS polymerase itself reducing its fidelity or improving its competitiveness; and modulation of the interactions of a TLS polymerase with its protein partners. An increase in genomic instability, a hallmark of cancer, has been linked to the (i) hindering of the normal replicase operation, (ii) imbalances in expression of DNA polymerases, (iii) lack of a relatively accurate TLS “polymerase of choice” responsible for bypassing a particular lesion in normal cells, or (iv) outcompeting the polymerase by another, less accurate enzyme [reviewed in (Beagan and McVey, 2016; Ghosal and Chen, 2013; Guo et al , 2013; Jansen et al , 2015; Knobel and Marti, 2011; Lange et al , 2011; Loeb and Monnat, 2008; Luo et al , 2012; Makridakis and Reichardt, 2012; Nicolay et al , 2012b; Parsons et al , 2013; Pillaire et al , 2014; Sharma et al , 2013; Shcherbakova and Fijalkowska, 2006; Sweasy et al , 2006; Yousefzadeh et al , 2014)].…”